colorectal cancer

Tumor factor spurs blood vessel growth

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.

Illustration of human intestinal tract

$5.2M NIH grant bolsters colorectal cancer research

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.

Vanderbilt, GE unite to study colon tumor development

Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.

Three new genetic links to colorectal cancer revealed

Vanderbilt-Ingram Cancer Center investigators have identified three new genetic “hotspots” linked to colorectal cancer.

Green tea found to reduce rate of some GI cancers

Green tea may lower risk of some digestive cancers.

An orphan enzyme’s purpose

“Orphan” enzyme may play role in cancer growth, new research suggests.

1 3 4 5 6